Biotechnology
News Category
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC®-TCE Development
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC®-TCE progra...
Onco-Innovations Advances Precision Oncology with Biomarker-Driven Cancer Therapy ONC010
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the industry shift tow...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma's receipt of a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 treatment advance...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform for Solid Tumors
VERAXA Biotech AG announced the appointment of Christoph Erkel as Chief Scientific Officer, effective immediately, to lead the development of its prop...
iOrganBio Appoints Lee L. Rubin, Ph.D. to Scientific Advisory Board to Advance Neurological Applications
iOrganBio expands its Scientific Advisory Board with stem cell biology authority Lee L. Rubin, Ph.D., aiming to enhance its CellForge platform for neu...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives announced it has finalized commercial manufacturing and supply chain logistics, enabling the rollout of its MyndSystem and Xcellara welln...
Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery
Creative Biolabs has launched an integrated microfluidics platform combining droplet generation systems, customizable chips, and immune checkpoint ser...
Quantum BioPharma Develops Dual Strategy Targeting Multiple Sclerosis and Alcohol Intoxication
Quantum BioPharma is advancing a pipeline addressing multiple sclerosis with its novel drug Lucid-MS and alcohol-related cognitive effects with unbuzz...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy Sapu003
Oncotelic Therapeutics released preclinical data in Biomedicines for its intravenous everolimus formulation Sapu003, showing improved pharmacokinetics...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma Ltd. has partnered with Bayer to study its lead antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate...
VERAXA Biotech Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC(R)-TCE program,...
VivoSim Labs Raises $4 Million in Private Placement with Healthcare-Focused Investor
VivoSim Labs announced a $4 million private placement with a healthcare investor, issuing shares and warrants to fund working capital and general corp...
Greenwich LifeSciences Provides Update on Phase 3 FLAMINGO-01 Trial, Announces Expanded Study Design
Greenwich LifeSciences announced that its Phase 3 FLAMINGO-01 trial for GLSI-100, an immunotherapy to prevent breast cancer recurrence, received DSMB ...
Quantum BioPharma Develops Two-Pronged Attack on Brain Disorders Affecting Millions
Quantum BioPharma Ltd. is advancing a pipeline targeting multiple sclerosis and alcohol intoxication, offering novel approaches to neurological condit...
American Fusion Secures Texas Certificate of Registration for Texatron Fusion Engine Testing
American Fusion has received a Texas DSHS Certificate of Registration allowing R&D on its Texatron Fusion Engine systems at Texas Tech University, adv...
WHO-Commissioned Study Finds No Evidence Linking Mobile Phones to Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, potentially easing long-...
Quantum BioPharma Hits Halfway Mark in MS Imaging Study, Early Data Shows Promise
Quantum BioPharma announced that its imaging study for multiple sclerosis has reached 50% patient enrollment, with preliminary PET imaging data showin...
GeoVax Highlights GEO-MVA Platform Alignment with HHS/ASPR Five-Year Biodefense Strategy
GeoVax's GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year plan emphasizing domestic manufacturing, platform technologies, and SNS moderni...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced it has received Scientific Advice from Germany's Paul-Ehrlich-Institute, providing clarity on the development plan for its Bi...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform, Advancing Toward Clinical Development
VERAXA Biotech announced positive regulatory feedback from Germany's Paul-Ehrlich-Institute on its BiTAC-TCE platform, supporting its dual-targeting a...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials announced a Japanese patent allowance for its GelrinC manufacturing process, expanding its IP portfolio and strengthening its po...
MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment from short speech samples, targeting wo...
Gut Microbiome Metabolites Linked to Improved Immunotherapy Response
New research identifies gut microbial metabolites that may enhance cancer immunotherapy efficacy, offering potential biomarkers for patient selection ...
SS Innovations Appoints Veteran Medtech Finance Executive as CFO Amid Global Robotic Surgery Expansion
SS Innovations International has appointed Sarah M. Romano as CFO, bringing public-company finance expertise as the company pursues FDA clearance for ...
Creative Biolabs Combines Microfluidics and Electrochemical Biosensors for Advanced POCT Diagnostics
Creative Biolabs has integrated microfluidics with electrochemical biosensors to accelerate the development of next-generation point-of-care testing p...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its cellular wellness platform strategy combining a stem cell mobilization base with tissue-specific ingredients, with the first...
NeuroOne Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic to evaluate a novel treatment approach for pediatric diffuse midline glioma, ...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform to Aid Biotech Firms
Oncotelic Therapeutics has introduced an AI-driven manufacturing services platform combining its PDAOAI architecture with robotics to help emerging bi...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trials for Multiple Sclerosis
Quantum BioPharma (NASDAQ: QNTM) progresses its neuroprotective therapy LUCID-MS, targeting myelin restoration in MS, after positive Phase 1 safety da...
VERAXA Biotech Leverages AI Partnership to Accelerate Cancer Therapy Development
VERAXA Biotech's collaboration with AI-focused Ardigen aims to enhance its BiTAC oncology platform through AI-enabled target discovery, potentially re...
Tonix Pharmaceuticals' Mpox Research Reveals Significant Virulence Differences, Bolstering TNX-801 Vaccine Development
Tonix Pharmaceuticals published preclinical research in the Journal of Virology showing that the mpox clade IIb strain circulating in the U.S. is up t...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline Programs
Nuvectis Pharma announced the pricing of a $100 million public offering, with proceeds intended to fund the development of its NXP100, NXP200, and NXP...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced promising interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for advanced EGFR-mutated NSCLC, ...
NeuroThera Labs Initiates Phase IIb Trial at Hannover Medical School for Tourette Syndrome Treatment
NeuroThera Labs has started its Phase IIb clinical trial at Hannover Medical School in Germany for SCI-110, a cannabinoid-based treatment for Tourette...
Earth Science Tech Leverages Telehealth and Peptide Therapies to Strengthen Market Position
Earth Science Tech Inc. (ETST) is capitalizing on the growing telehealth and peptide therapy markets through its subsidiaries and proprietary technolo...
Formycon and OneSource Specialty Pharma Forge Strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to leverage OneSource's biologics facility in India for ...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trial for Multiple Sclerosis
Quantum BioPharma reported positive Phase 1 safety data for its neuroprotective therapy LUCID-MS and has submitted an IND to the FDA, positioning it f...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS into Phase 2 Trials
Quantum BioPharma progresses its neuroprotective therapy LUCID-MS, designed to reverse myelin degradation in multiple sclerosis, into Phase 2 clinical...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program
Silo Pharma's subsidiary QwikAgents has been accepted into AMD's AI Developer Program, gaining access to tools and resources to accelerate its AI agen...
VERAXA Biotech’s AI Partnership Highlights Growing Role of Artificial Intelligence in Cancer Drug Development
VERAXA Biotech AG’s collaboration with AI firm Ardigen underscores how artificial intelligence is enhancing target discovery and reducing risks in onc...
DN Group's Subsidiary Algene Hits Milestone with First Microalgae Harvest, Eyes Growing Market
Algene Holding SE, a subsidiary of DN Group AG, has successfully completed its first harvest of high-purity microalgae, achieving 4,500 liters and ini...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech (NASDAQ: VRXA) has announced a collaboration with Ardigen S.A. to integrate artificial intelligence into its BiTAC T-cell engager pipel...
NanoViricides Gets Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides received ethics committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against Bundibugyo ebolavirus, aiming to p...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to 145 Million Lives
Tonix Pharmaceuticals announced a managed Medicare agreement for TONMYA, adding 9 million beneficiaries and expanding total pharmacy coverage to appro...
VERAXA Biotech and Ardigen Collaborate to Enhance AI-Driven Cancer Drug Development
VERAXA Biotech partners with Ardigen to integrate AI into its BiTAC pipeline, aiming to improve target selection and reduce toxicity in cancer therapi...
Onco-Innovations Completes Analytical Reference Standard Program for ONC010, Advancing Oncology Candidate Toward Clinical Readiness
Onco-Innovations Limited has finalized its analytical reference standard for ONC010's active ingredient, strengthening its CMC framework and supportin...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Growth Phase
VERAXA Biotech has appointed Carl von Halem as interim CFO, leveraging his experience in corporate finance and life sciences to support the company's ...
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence and Enhances Safety in Preclinical Study
A new preclinical study presents a feeder-free TIL expansion protocol that minimizes IL-2 usage while maintaining anti-tumor efficacy, and combining i...